We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI-Guided Breast Biopsy Device

By HospiMedica staff writers
Posted on 16 Jun 2006
A magnetic resonance imaging (MRI)-guided breast biopsy device is now available to help clinicians accurately diagnose women who are at high risk for breast cancer and have lesions that cannot be accurately detected with mammography or ultrasound. More...


According to the American Cancer Society, high-risk patients include those with a family history or a previous diagnosis of breast cancer and those with dense breast tissue or breast implants.

The device, called the Mammotome MR, was developed by Ethicon Endo-Surgery, Inc. (EES; Cincinnati, OH, USA). "The Mammotome MR with vacuum assistance helps doctors obtain sufficient tissue to accurately diagnose the smallest of breast abnormalities without open surgery,” said Kathy Schilling, M.D., medical director of Imaging and Intervention Women's Center/Center for Breast Care at Boca Raton Radiology Group (FL, USA). "This is an important new option for high risk women.”

A procedure with the Mammotome MR involves the single insertion of a needle equipped with a vacuum device into a tiny _-inch incision (about the size of a match head). Under MRI guidance, the device gently vacuums, cuts, and partially or completely removes suspicious breast tissue for assessment. The biopsy incision is so small only an adhesive bandage is needed to cover it and no stitches are required. Most patients return to normal activity immediately following the procedure. The outpatient procedure can be performed in an MRI suite and usually takes less than an hour. Scarring is minimal.

"The Mammotome can now be used with all three imaging modalities including stereotactic, ultrasound, and MRI, to detect and diagnose breast abnormalities,” said Lucia Buehler, group product director, Ethicon Endo-Surgery.

The device has a unique hands-free holster with feedback display for procedural focus, and the device's targeting sleeve is the only system that currently allows physicians to visualize the sampling area/aperture in MR. A new localization system provides better access to the breast. Furthermore, anesthesia can be administered throughout the procedure using the system's targeting set and vacuum tubing.

The system can be purchased in its entirety or as an upgrade to an existing Mammotome breast biopsy system. Multiple needle lengths and gauge sizes allow physicians to accurately target both lateral and medial lesions as well as rapidly acquire tissue based on individual patient/lesion characteristics. The Mammotome MR is compatible with many magnet, breast coil, and computer-aided-detection (CAD) options.



Related Links:
Ethicon Endo-Surgery

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.